[Pharmacokinetics of glyprolines (PGP) upon intragastric administration].

The pharmacokinetics of glyprolines upon intragastric administration in rats was studied by monitoring the content of tritium-labeled PGP in the blood plasma and protein, in organs (for 5 h), and urine (for 8 h). The maximum radioactivity (2.25% of the introduced level) in the blood plasma was observed 15 min after administration of [3H]-PGP. Then, the radioactivity level gradually decreased, but even in 5 h it exceeded 1%. In contrast, the radioactivity of deposited protein gradually increased. The content of labeled PGP and its metabolites in organs was much lower than in the blood. The radioactivity 15 min after administration was as follows (%): intestine, 1.4; stomach, 0.1; liver, 0.09; brain, heart, and kidney, < 0.05; in 5 h, the radioactivity level was below 0.02% (except for intestine, where it was still greater than 0.1%). No labeled PGP or its metabolites were found in the urine during the 8-h period of observations. It is not excluded that glyprolines introduced with PGP are involved in the synthesis of new peptides and proteins, including collagen.